Ensure appropriate use of soft restraints, drugs
Briefings on The Joint Commission, July 1, 2008
This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Briefings on The Joint Commission.
Editor’s note: Sue Dill Calloway, RN, MSN, JD, director of hospital risk management for OHIC Insurance Company, The Doctor’s Company, in Columbus, OH, is the “CMS corner” lead contributor. Submit a topic idea to her by contacting BOJ Managing Editor Matt Phillion at mphillion@hcpro.com.
In the June issue, we began our discussion on restraints, following the recent release of CMS’ interpretive guidelines on the subject. This month, we will continue our discussion by addressing soft limb restraints and drugs as restraints.
This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Briefings on The Joint Commission.
Comments
0 comments on “Ensure appropriate use of soft restraints, drugs ”
Related Products
Most Popular
- Articles
-
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- HIPAA Q&A: TPO disclosures to a business associate
- Q/A: Coding infusions to correct low potassium levels
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- The debate continues: Nurses who reported physician to the Texas Medical Board file federal appeal
- State medical board will hear unprofessional charges against OB-GYN
- Capturing all necessary codes for IUD insertion and removal can be challenging
- QA:Coding multiple initial infusions
- Major mobile operators to support free text alerts
- E-mailed
-
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Q/A: Coding infusions to correct low potassium levels
- Know criteria for coverage when podiatrists use Dermagraft® tissue substitute
- Note: Clarification of reference (non-patient) laboratory testing
- HIPAA Q&A: TPO disclosures to a business associate
- Get the facts on coding for non-biodegradeable drug delivery implants
- Facility E/M Levels, 2009 OPPS
- Do not separately report defibrillation
- Defining 'integral' for self-administered drugs is challenging
- Consider the big picture before querying physicians
- Searched
